Literature DB >> 9467579

Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect.

B A Gabreëls1, D F Swaab, D P de Kleijn, N G Seidah, J W Van de Loo, W J Van de Ven, G J Martens, F W van Leeuwen.   

Abstract

7B2 is a neuroendocrine chaperone interacting with the prohormone convertase PC2 in the regulated secretory pathway. Its gene is located near the Prader-Willi syndrome (PWS) region on chromosome 15. In a previous study we were able to show 7B2 immunoreactivity in the supraoptic nucleus (SON) or the paraventricular nucleus (PVN) in only three of five PWS patients. Here we report that in contrast with five other PWS patients, the neurons in the hypothalamic SON and PVN of the two 7B2-immunonegative PWS patients also failed to show any reaction using two antibodies directed against processed vasopressin (VP). On the other hand, even these two cases reacted normally with five antibodies that recognize different parts of the VP precursor. This finding pointed to a processing defect. Indeed, the same patients had no PC2 immunoreactivity in the SON or PVN, whereas PC1 immunoreactivity was only slightly diminished. In conclusion, in the VP neurons of two PWS patients, greatly reduced amounts of 7B2 and PC2 are present, resulting in diminished VP precursor processing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467579     DOI: 10.1210/jcem.83.2.4542

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Endocrinomic profile of neurointermediate lobe pituitary prohormone processing in PC1/3- and PC2-Null mice using SELDI-TOF mass spectrometry.

Authors:  Atira Hardiman; Theodore C Friedman; William C Grunwald; Machi Furuta; Ziaorong Zhu; Donald F Steiner; David R Cool
Journal:  J Mol Endocrinol       Date:  2005-06       Impact factor: 5.098

Review 2.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Structural Requirements for Sorting Pro-Vasopressin to the Regulated Secretory Pathway in a Neuronal Cell Line.

Authors:  David R Cool; Steven B Jackson; Karen S Waddell
Journal:  Open Neuroendocrinol J       Date:  2008-01-01

4.  Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control.

Authors:  S Lee; R Wevrick
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

5.  Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome.

Authors:  Merlin G Butler; Douglas C Bittel; Zohreh Talebizadeh
Journal:  J Pediatr Endocrinol Metab       Date:  2004-09       Impact factor: 1.634

6.  Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome.

Authors:  Merlin G Butler; Douglas C Bittel
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

7.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

8.  Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome?

Authors:  Joseph Polex-Wolf; Giles S H Yeo; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

9.  The role of proopiomelanocortin (POMC) neurones in feeding behaviour.

Authors:  George Wm Millington
Journal:  Nutr Metab (Lond)       Date:  2007-09-01       Impact factor: 4.169

Review 10.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.

Authors:  Felipe Correa-da-Silva; Eric Fliers; Dick F Swaab; Chun-Xia Yi
Journal:  J Neuroendocrinol       Date:  2021-06-22       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.